• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

    4.950 +0.100 (+2.06%)
    Streaming Delayed Price Updated: 10:34 AM EDT, Jul 31, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about CNS Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    23 24 Next >
    News headline image
    CNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update
    Via ACCESS Newswire
    Simple Hand Motion Test Could Reveal Undetected Brain Tumor
    Via Investor Brand Network
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Prices $5 Million Public Offering with Institutional Investor
    Via Investor Brand Network
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
    Via Chartmill
    News headline image
    CNS Pharmaceuticals Reports Full Year 2024 Financial Results
    Via ACCESS Newswire
    News headline image
    Which stocks are moving before the opening bell on Tuesday? ↗
    Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session. 
    Via Chartmill
    News headline image
    CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
    Via ACCESS Newswire
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Orphan Drug Designation Transfer for TPI 287 in Brain Cancer Indications
    Via Investor Brand Network
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
     
    Via Benzinga
    Study Reveals Early Development of Pediatric Brain Tumors in Specialized Nerve Cells
    Via Investor Brand Network
    AI Can Predict the Recurrence of Brain Tumors in Kids, Study Finds
    Via Investor Brand Network
    Topics Artificial Intelligence
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
     
    Via Benzinga
    Study Identifies Key Enzyme That Could Be Targeted to Fight Brain Cancers
    Via Investor Brand Network
    The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035
    Via Investor Brand Network
    News headline image
    Top stock movements in today's session. ↗
    Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
    Via Chartmill
    News headline image
    The market is filled with gapping stocks in Tuesday's session. ↗
    There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday. 
    Via Chartmill
    News headline image
    Study Uncovers Drivers of Brain Tumor Growth, Could Open New Treatment Approaches
    Via Investor Brand Network
    News headline image
    Pitt Researchers Develop Diagnostic Tool for Profiling Pediatric Brain Cancers
    Via Investor Brand Network
    News headline image
    InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances TPI 287 for GBM, Ends 2024 with Strong Cash Position
    Via Investor Brand Network
    Firefighters Have an Increased Chance of Having Gene Mutations Associated with Brain Cancer, Study Says
    Via Investor Brand Network
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-03-25: top gainers and losers in today's session. ↗
    Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
    Via Chartmill
    News headline image
    Which stocks are experiencing notable movement on Tuesday? ↗
    Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
    Via Chartmill
    News headline image
    Nasdaq Gains 50 Points; US New Home Sales Rise In February ↗
     
    Via Benzinga
    News headline image
    CNS Pharma's Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects ↗
    CNS Pharmaceuticals' Berubicin trial results show a favorable safety profile with no cardiotoxicity and comparable efficacy to Lomustine in recurrent GBM. 
    Via Benzinga
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Phase 2 Results for Berubicin in Glioblastoma Trial
    Via Investor Brand Network
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    23 24 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.